US 11660296
Treatment of chronic cough, breathlessness and dyspnea
granted A61KA61K31/485A61K45/06
Quick answer
US patent 11660296 (Treatment of chronic cough, breathlessness and dyspnea) held by Trevi Therapeutics, Inc. expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Trevi Therapeutics, Inc.
- Grant date
- Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/485, A61K45/06, A61K9/2009, A61K9/2013